Related Experiment Video
Updated: Dec 25, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
[The influence of serotonin on psychosomatic symptoms in patients with functional dyspepsia]
Paulina Mikulska1, Jan Chojnacki1, Agnieszka Stępień1
1Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University, Lodz.
Abstract:
The pathogenesis of functional dyspepsia is remains unknown. The diagnosis is based on subjective symptoms. However, many effort are being made in searching for the causes and objective indices which could facilitate the diagnosis and the treatment of this disease.
Aim:
The aim of study was to evaluate the indices of serotonin synthesis and metabolism in patients with functional dyspepsia in relation to psychosomatic symptoms.
Materials And Methods:
The study comprised 30 healthy subjects (group I - control) and 30 patients with functional dyspepsia(group II) as postprandial distress syndrome (PDS), according to Rome Criteria IV. Assessment of the severity of dyspeptic symptoms was performed using a 10-point visual-analogue scale(VAS). All patients completed the Hamilton Depression Scale. Serum serotonin and 5-hydroxyindoleacetic acid (5-HIAA) concentration in urine were measured by ELISA method using IBL antibodies (catalog numbers- RE-59121, RE-59131).
Results:
Serum serotonin concentration in the control group was 205.1±34.1 ng/ml, and in dyspeptic patients - 154.2±52.9 ng/ml (p<0.001). Significant differences were also found in daily urinary 5-HIAA excretion: 6.88±0.79 mg/24h vs 5.06±1.25 mg/24h, respectively ( p < 0.001). Moreover, a negative correlation was found between serotonin concentration as well as urinary 5-HIAA excretion and severity of depressive symptoms. The correlation between severity of dyspeptic and psychic symptoms was poorly positive.
Conclusions:
These results indicate that in patients with functional dyspepsia homeostasis of serotonin is disturbed, and it is in relation to psychosomatic symptoms.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
The Placebo Effect

